Impact of FGFR3 genomic aberrations in patients with metastatic urothelial carcinoma treated with first line platinum-based chemotherapy by R. Morales Barrera, N. Díaz, C. Suarez, M. Gonzalez, E. Serra, F. Lozano, M. Altabas, C. Fernandez, M. Hernández, S. Gutierrez, M. Semidey, R. Mast, J.M. Rodriguez, S. Roche, C. Serrano, J. Mateo, C. Valverde, I. De Torres, X. Maldonado, J. Morote, J. Carles

Get full text